<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610449</url>
  </required_header>
  <id_info>
    <org_study_id>7113211</org_study_id>
    <nct_id>NCT05610449</nct_id>
  </id_info>
  <brief_title>Assessing Performance of the Testing Done Simple Covid 19 Antigen Test</brief_title>
  <official_title>Assessing Performance of the Testing Done Simple Covid 19 Antigen Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Testing Done Simple</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nao Medical Urgent Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Testing Done Simple</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will measure the sensitivity and specificity of the Testing Done Simple severe&#xD;
      acute respiratory syndrome (SARS) CoV-2 antigen test in subjects with suspected Covid-19 that&#xD;
      present throughout several urgent care clinics. The antigen test performance will be compared&#xD;
      to a real-time polymerase chain reaction (RT-PCR) test.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Testing Done Simple antigen test is a lateral flow immunoassay that detects the presence&#xD;
      of the SARS CoV-2 nucleoprotein and is primarily intended for use in an at home setting. The&#xD;
      antigen test will be compared to a traditional RT-PCR tested nasal swab specimens. The&#xD;
      purpose of study is to measure the performance of the Testing Done Simple test via&#xD;
      sensitivity and specificity when compared to the gold-standard RT-PCR test. The test will be&#xD;
      administered in symptomatic and asymptomatic subjects and participants will report the days&#xD;
      that has passed since their symptom onset. The RT-PCR test will be performed prior to the&#xD;
      Testing Done Simple test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 4, 2022</start_date>
  <completion_date type="Anticipated">March 29, 2023</completion_date>
  <primary_completion_date type="Actual">February 17, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>15 minutes</time_frame>
    <description>Sensitivity (True Positive Rate) of Testing Done Simple Antigen Test compared to RT-PCR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity</measure>
    <time_frame>15 minutes</time_frame>
    <description>Specificity (True Negative Rate) of Testing Done Simple Antigen Test compared to RT-PCR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity in Relation to the Time Since Symptom Onset in Symptomatic subjects</measure>
    <time_frame>15 minutes</time_frame>
    <description>Sensitivity of Testing Done Simple Antigen Test according to the days of symptom onset in symptomatic subjects</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Testing Done Simple Antigen test in Symptomatic Subjects (Nasal swab)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Testing Done Simple Antigen test in Asymptomatic Subjects (Nasal swab)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Testing Done Simple SARS CoV-2 Antigen Test</intervention_name>
    <description>Collections of specimens from subjects presenting with Covid-19 like symptoms or known/suspected exposure to SARS CoV-2 via nasal swabs administered by trained medical personnel.</description>
    <arm_group_label>Testing Done Simple Antigen test in Asymptomatic Subjects (Nasal swab)</arm_group_label>
    <arm_group_label>Testing Done Simple Antigen test in Symptomatic Subjects (Nasal swab)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The cohorts consist of a symptomatic group of patients with Covid related symptoms and an&#xD;
        asymptomatic group of patients that may have been exposed to Covid through another person&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject was given a SARS CoV 2 PCR test for any of the following 4 reasons:&#xD;
&#xD;
               1. Subject has Covid like symptoms that started within past (7) days&#xD;
&#xD;
               2. Subject has been exposed to another individual with a known Covid diagnosis or&#xD;
                  probable Covid diagnosis&#xD;
&#xD;
               3. Subject needs Covid test done for travel, school, work, etc&#xD;
&#xD;
               4. Subject works in a high risk environment&#xD;
&#xD;
          -  Subject can provide a nasal swab sample&#xD;
&#xD;
          -  Subject is at least 18 years of age&#xD;
&#xD;
          -  Subject was given a SARS CoV 2 PCR test on same day participating this study&#xD;
&#xD;
          -  Subject provides informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is less than 18 years of age&#xD;
&#xD;
          -  Subject does not provide consent&#xD;
&#xD;
          -  Subject's Covid 19 related symptom(s) started greater than 7 days from visit&#xD;
&#xD;
          -  Asymptomatic subjects whom have had symptom(s) within past (14) days&#xD;
&#xD;
          -  Signs of local infection in the area of the face&#xD;
&#xD;
          -  Subject was not given a SARS CoV 2 PCR test on same day as study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nao Medical Urgent Care-Astoria</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nao Medical Urgent Care-Jackson Heights</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11372</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>March 20, 2023</last_update_submitted>
  <last_update_submitted_qc>March 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Antigen test</keyword>
  <keyword>Test</keyword>
  <keyword>Diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

